BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer. (2022). Majalah Kedokteran Bandung, 54(4), 221-227. https://doi.org/10.15395/mkb.v54n4.2797